COMMUNIQUÉS West-GlobeNewswire
-
FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference
17/02/2026 -
Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
17/02/2026 -
Inventiva publie ses résultats financiers préliminaires pour l’exercice 2025¹
17/02/2026 -
Inventiva reports preliminary 2025¹ fiscal year financial results
17/02/2026 -
Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
16/02/2026 -
Galapagos Receives Transparency Notification from Bank of America
16/02/2026 -
Matterhorn Fit Debuts in Fort Lauderdale with Olympian and Florida Panthers alum Steven Kampfer at the Helm
16/02/2026 -
Betterbrand Founder Turns Family Tragedy Into Clinically-Studied Lung Support
16/02/2026 -
IBA – ACQUISITION D’ACTIONS PROPRES
16/02/2026 -
EssilorLuxottica: Disclosure of transactions in own shares
16/02/2026 -
EssilorLuxottica: Déclaration de transactions sur actions propres
16/02/2026 -
IBA – ACQUISITION OF OWN SHARES
16/02/2026 -
Enlightened Recovery Opens New 22-Bed Residential Treatment Facility in Egg Harbor Township, NJ
16/02/2026 -
Juvenescence appoints Eileen Jennings-Brown as Chief Technology Officer and strengthens presence in UAE with new partnership and facilities with Masdar City
16/02/2026 -
Novo Nordisk A/S - share repurchase programme
16/02/2026 -
Artios Strengthens Leadership Team to Accelerate Late-Stage Development of Potential First-in-Class Oncology Pipeline
16/02/2026 -
LEX Diagnostics Receives FDA 510(k) Clearance and CLIA Waiver for LEX VELO System
16/02/2026 -
Communiqué de presse : L’étude sur Beyfortus publiée dans la revue The Lancet Infectious Diseases montre ses bénéfices chez les nourrissons au-delà de la première saison du VRS
16/02/2026 -
Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season
16/02/2026
Pages